Kaiser Health News

King v. Burwell is closed, but the law's long-term future still isn't ensured.

To ease the financial burden, the California agency that governs the state's Affordable Care Act marketplace issued landmark rules recently that will limit the amount anyone enrolled in one of those plans can be charged each month for high-end medicine.

Some employers say a proposed rule could force them to cut the size of wellness programs’ financial incentives or penalties.

"The very advantage of telehealth, its ability to make care convenient, is also potentially its Achilles’ heel."

A scathing state audit shows that California is failing to make sure Medicaid managed care plans deliver their promises to patients.

CBO projected that a repeal would increase the federal deficit by $353 billion over 10 years because of higher direct federal spending on health programs such as Medicare and lower revenues.

A bipartisan group of House and Senate legislators introduced bills last week that would require health plans to cover the growing number of oral chemotherapy pills as favorably as they do intravenous chemotherapy.

The issue is whether the section means what it seems to say if read literally and in isolation from the rest of the Affordable Care Act.

Nearly three in four Americans say the costs of prescription drugs are "unreasonable," with most putting the blame on drugmakers, a survey by the Kaiser Family Foundation found.

Medicare drug plans are cutting back on coverage for a specially designated type of painkiller that deters abuse in favor of cheaper generics that don't have the same deterrent qualities, a new study found.